🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors

RecruitingNAAges 18 Years - 100 YearsFemaleUniversity of Aarhus
NCT06007027 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This project will be based on three studies over a period on three years. The first study is a dose response study that includes 30 breast cancer survivors. They will receive a total of 5 laser treatments with 4-6 weeks intervals The second study is a double-blind randomized controlled trial, that includes 60 breast cancer survivors. 30 of those will receive active intervention and 30 will receive placebo laser treatment and act as controls. Based on the results of the dose response study, a treatment consists of three to five laser treatments every 3 weeks. The third and last study is a one-year follow-up on study two. The conditions are evaluated before and after each treatment by questionnaires, vaginal fluid pH values, punch biopsies and vaginal and urine microbiome. The studies is conducted at the Department of Obstetrics and Gynaecology at Randers Regional Hospital in collaboration

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Breast cancer survivor in endocrine therapy * Symptomatic genitourinary symdrom of menopause with vaginal discomfort and/or dyspareunia * Able to read and understand Danish * Able to give written informed consent Exclusion Criteria: * Pelvic organ prolapse ≥ stage 2 according to the Pelvic Organ Prolapse Quantification staging system * Use of non-hormonal/hormonal vaginal therapies (1 and 12 months prior to the baseline visit, respectively) * Use of Chemotherapy (6 months prior to the baseline visit) * Acute urinary tract infection or active genital infection * History of vaginal reconstructive surgery
💊

What it tests

  • SmartXIDE2V2LR, Monalisa Touch, DEKA, Florence, Italy
📍

Where

1 site
Department of Obstetrics and Gynaecology, Randers Regional Hospital
Randers, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy